NCM · Biotechnology

SXTP (SXTP) Stock

$1.50 -4.60% NCM: SXTP Healthcare

Valuation

MetricValue
Price$1.50
Market Cap$1.21M
P/E Ratio-0.12
P/B Ratio0.38
P/S Ratio1.20
EPS (TTM)$-11.73
52-Week High$10.77
52-Week Low$1.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-2.01%
ROA-87.17%
ROCE-266.67%
Gross Margin-800.00%
Operating Margin-800.00%
Net Margin-7.55%
Debt/Equity0.03
Current Ratio2.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$0$1.0M$1.0M
Operating Profit$-1.0M$-2.0M$-5.0M$-10.0M$-8.0M
Net Profit$-4.0M$-6.0M$-4.0M$-8.0M$-7.0M
EPS$-2.96$-4.28$-3.80$-74.20$-11.73
Op Margin-96.9%-784.2%-2032.8%-1599.0%-771.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$1.0M$8.0M$6.0M$5.0M
Total Liabilities$20.0M$25.0M$3.0M$2.0M$2.0M
Cash$0$0$2.0M$2.0M$2.0M
Borrowings$19.0M$22.0M$0$0$0

Latest News

60 Degrees Pharmaceuticals to Advance Castanospermine for Tick-Borne Diseases Through Florida State University Deal MT Newswires · Jul 8, 2026 60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases GlobeNewswire · Jul 8, 2026 60 Degrees Pharmaceuticals Says Safety Board Recommends Continuing Babesiosis Trial MT Newswires · Jul 1, 2026 60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue GlobeNewswire · Jul 1, 2026 60 Degrees Pharmaceuticals Licenses Patent to Produce Australian Chestnut Extract MT Newswires · Jun 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$-5.0M$-6.0M$-7.0M
Investing Cash Flow$0$0$0$-2.0M$0
Financing Cash Flow$0$0$1.0M$0$0
Net Cash Flow$0$0$2.0M$0$0
Free Cash Flow$-1.0M$-1.0M$-5.0M$-6.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-683.66%
Quick Ratio2.85
Interest Coverage—
Return 1Y-77.86%
Return 3Y-99.83%
Return 5Y—

Ownership

Insiders Held0.88%
Institutions Held9.60%
Institutions Float Held9.68%
Institutional HolderSharesReport Date
Kathmere Capital Management, Llc144,6832026-03-31
UBS Group AG31,4102026-03-31
Geode Capital Management, LLC16,2952026-03-31
Barclays Plc1,8562026-03-31
Twin Peaks Wealth Advisors, LLC 82026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDRXBiodexa Pharmaceuticals Plc $1.71 -3.39% 0.00 $1.28M 0.00%
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CLDI $0.11 +0.18% -0.03 $802266 0.00%
CMND $1.62 +0.52% -0.79 $2.41M 0.00%
CNSP $5.40 +0.75% -0.14 $3.10M 0.00%

About SXTP

SXTP is led by CEO Geoffrey Stuart Dow, employs 3 people, headquartered in US, publicly traded since 2023.

SXTP stock trades at $1.50 with a market capitalization of $1.21M. The stock is valued at a price-to-earnings (P/E) ratio of -0.12, price-to-book of 0.38, price-to-sales of 1.20. Over the past 52 weeks the stock has ranged between $1.22 and $10.77, and currently trades 86.1% below its 52-week high.

On profitability, SXTP generates a return on equity (ROE) of -2.01%, return on capital employed of -266.67%, an operating margin of -800.00%, a net profit margin of -7.55%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides